Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Ligand Enters Into Worldwide OmniAb® Platform License Agreement With xCella Biosciences

Wednesday, May 31, 2017

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide license agreement with Menlo Park Californiabased xCella Biosciences Inc Under the license xCella will be able to use the OmniRat OmniMouse and OmniFlic platforms to discov...

Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration

Wednesday, May 31, 2017

Array BioPharma and BristolMyers Squibb Company announced the companies have entered into a clinical research collaboration to investigate the safety tolerability and efficacy of Arrays investigational MEK inhibitor binimetinib in combination with Br...

Celyad obtains additional US patent for cancer treatment based on TCR-deficient allogeneic CAR-T cells

Tuesday, May 30, 2017

Celyad a leader in the discovery and development of engineered cell therapies today announced the issuance of United States Patent No relating to Celyads method of treating cancer by administering allogeneic primary human T cells that are engineered...

Lysogene Completes Enrollment in First International Pivotal Observational Study in MPS IIIA

Tuesday, May 30, 2017

Lysogene a leading biopharmaceutical company pioneering gene therapy technologies to treat central nervous system diseases today announced the completion of enrollment in its Sanfilippo A Multinational Observational Study SAMOS Sanfilippo A is also k...

Glenmark Pharma gets ANDA approval for nebivolol tablets

Monday, May 29, 2017

Glenmark Pharmaceuticals Ltd Says receives ANDA approval for nebivolol tablets mg mg mg and mg Co may be eligible for days of generic drug exclusivity for nebivolol tablets mg mg mg and mg

BioPharma Services, Inc. Successfully Completes 3 FDA Inspections with ZERO Form 483’s

Monday, May 29, 2017

BioPharma Services Inc is proud to announce that it has successfully completed inspections this month by the US FDA with concurrent audits at both research centers in Toronto Canada and Columbia Missouri Over the course of weeks the backtoback insp...

Kite Receives U.S. Food and Drug Administration Priority Review for Axicabtagene Ciloleucel

Saturday, May 27, 2017

Kite Pharma Inc a leading cell therapy company announced that the US Food and Drug Administration FDA has accepted for priority review the Biologics License Application BLA for axicabtagene ciloleucel The submission follows positive data demonstrated...

Novartis receives FDA approval for expanded use of Zykadia®

Saturday, May 27, 2017

Novartis today announced the US Food and Drug Administration FDA approved the expanded use of Zykadia ceritinib to include the firstline treatment of patients with metastatic nonsmall cell lung cancer NSCLC whose tumors are anaplastic lymphoma kinase...

PharmaMar and Eczacibasi Sign a Licensing Agreement for Aplidin® in Turkey

Friday, May 26, 2017

PharmaMar has announced a licensing agreement with Eczacibasi Group to commercialize the marinederived anticancer drug Aplidin plitidepsin in Turkey Under the terms of the agreement PharmaMar will receive an upfront payment as well as development mil...

Optum and Merck Collaborate to Advance Value-Based Contracting of Pharmaceuticals

Friday, May 26, 2017

Optum the health services business of UnitedHealth Group and Merck will collaborate to develop and simulate the performance of contractual reimbursement models in which payment for prescription drugs is aligned more closely with patient health outcom...